Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI
Author:
Funder
Celgene
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00403-022-02343-1.pdf
Reference45 articles.
1. Taïeb A, Picardo M (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20(1):27–35
2. Conic RZ, Tamashunas NL, Damiani G, Fabbrocini G, Cantelli M, Bergfeld WF (2020) Comorbidities in pediatric alopecia areata. J Eur Acad Dermatol Venereol 34(12):2898–2901
3. Malerba M, Damiani G, Radaeli A, Ragnoli B, Olivini A, Calzavara-Pinton PG (2015) Narrowband ultraviolet B phototherapy in psoriasis reduces proinflammatory cytokine levels and improves vitiligo and neutrophilic asthma. Br J Dermatol 173(6):1544–1545
4. Mineiro Dos Santos Garrett NF, Carvalho da Costa AC, Barros Ferreira E, Damiani G, Diniz Dos Reis PE, Inocêncio Vasques C. Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis. PLoS One. 2021;16(8):e0255716.
5. Ciccarese G, Drago F, Boldrin S, Pattaro M, Parodi A (2022) Sudden onset of vitiligo after COVID-19 vaccine. Dermatol Ther. 35(1):e15196
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of aryl hydrocarbon receptor in vitiligo: a review;Frontiers in Immunology;2024-02-01
2. JAK inhibitors for the treatment of vitiligo;Journal of Dermatological Science;2024-01
3. Vitiligo. Novel Treatment Modalities. Small Molecule Inhibitors and Cytokine-Targeted Treatments;J BIOL REG HOMEOS AG;2023
4. Apremilast Add-On Benefits Over Conventional Drugs (ABCD) in Unstable Non-segmental Vitiligo: A 12-Week Single-Center Randomized Controlled Trial;Cureus;2023-04-05
5. Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art;International Journal of Molecular Sciences;2023-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3